Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

Delayed Data
As of Oct 06
 -1.43 / -2.79%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Major

Company Description

Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company operates through the following segments: Pharmaceutical, Animal Health and Alliances. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the company or through joint ventures. Its human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The company sells these products primarily to drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Its vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices. The company sells these vaccines primarily to physicians, wholesalers, physician distributors and government entities. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines, which it sells to veterinarians, distributors and animal producers. The Alliances segment includes revenue from the company relationship with AstraZeneca LP. The company was founded in 1851 and is headquartered in Kenilworth, NJ.

Contact Information

Merck & Co., Inc.
2000 Galloping Hill Road
Kenilworth New Jersey 07033
P:(908) 740-4000
Investor Relations:
(908) 740-1986



Mutual fund holders41.68%
Other institutional34.41%
Individual stakeholders0.08%

Top Executives

Kenneth C. FrazierChairman, President & Chief Executive Officer
Robert M. DavisChief Financial Officer & Executive Vice President
Clark GolestaniChief Information Officer & Executive VP
Michael A. RosenblattChief Medical Officer & Executive Vice President
Michael J. HolstonExecutive VP, Chief Ethics & Compliance Officer